Prosecution Insights
Last updated: April 19, 2026

Akeso Biopharma, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17996878 ANTI-CD73-ANTI-PD-1 BISPECIFIC ANTIBODY AND USE THEREOF BENAVIDES, JENNIFER ANN 1675 Non-Final OA Oct 21, 2022
17779425 ANTI-PD-1-ANTI-VEGFA BISPECIFIC ANTIBODY, PHARMACEUTICAL COMPOSITION AND USE THEREOF HOPKINS, SAMANTHA LAKE 1641 Non-Final OA May 24, 2022

Managing Akeso Biopharma, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month